Chlorine in PDB, part 400 (files: 15961-16000),
PDB 6ew6-6f1l
Experimental structures of coordination spheres of Chlorine (Cl) in bioorganic
molecules from X-Ray and NMR experiments. Coordination spheres were calculated with 5.0 Angstroms radius
around Chlorine atoms. PDB files: 15961-16000 (PDB 6ew6-6f1l).
-
6ew6 (Cl: 1) - Crystal Structure of the BCL6 Btb Domain in Complex with Anilinopyrimidine Ligand
-
6ew7 (Cl: 6) - Crystal Structure of the BCL6 Btb Domain in Complex with Anilinopyrimidine Ligand
Other atoms:
F (2);
-
6ew8 (Cl: 2) - Crystal Structure of the BCL6 Btb Domain in Complex with Anilinopyrimidine Ligand
-
6ex7 (Cl: 3) - Crystal Structure of Ndm-1 Metallo-Beta-Lactamase in Complex with Cd Ions and A Hydrolyzed Beta-Lactam Ligand - New Refinement
Other atoms:
Cd (6);
-
6ex8 (Cl: 2) - Crystal Structure of Rhodesain in Complex with A Macrolactam Inhibitor
Other atoms:
F (6);
-
6exo (Cl: 2) - Crystal Structure of Rhodesain in Complex with A Macrolactam Inhibitor
-
6exq (Cl: 2) - Crystal Structure of Rhodesain in Complex with A Macrolactam Inhibitor
-
6ey7 (Cl: 1) - Human Cytomegalovirus Terminase Nuclease Domain, Mn Soaked, Inhibitor Bound
Other atoms:
F (4);
Mn (10);
-
6ey8 (Cl: 1) - Estimation of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
-
6ey9 (Cl: 1) - Estimation of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
-
6ez2 (Cl: 1) - Human Butyrylcholinesterase Carbamylated.
-
6ez9 (Cl: 1) - X-Ray Structure of Human Glutamate Carboxypeptidase II (Gcpii) - the E424M Inactive Mutant, in Complex with A Inhibitor JHU3372
Other atoms:
Ca (1);
Zn (2);
-
6eza (Cl: 2) - Crystal Structure of Human Trna-Dihydrouridine(20) Synthase Catalytic Domain E294K Mutant
-
6ezc (Cl: 1) - Crystal Structure of Human Trna-Dihydrouridine(20) Synthase Catalytic Domain E294K Q305K Double Mutant
-
6ezf (Cl: 2) - PDE2 in Complex with Molecule 5
Other atoms:
Mg (1);
Zn (1);
Na (1);
-
6ezg (Cl: 2) - Torpedo Californica Ache in Complex with Indolic Multi-Target Directed Ligand
-
6ezh (Cl: 2) - Torpedo Californica Ache in Complex with Indolic Multi-Target Directed Ligand
-
6ezo (Cl: 2) - Eukaryotic Initiation Factor EIF2B in Complex with Isrib
-
6ezp (Cl: 1) - Cathepsin L in Complex with (3S,14E)-19-Chloro-N-(1-Cyanocyclopropyl)- 5-Oxo-12,17-Dioxa-4-Azatricyclo[16.2.2.06,11]Docosa-1(21),6(11),7,9, 14,18(22),19-Heptaene-3-Carboxamide
-
6ezx (Cl: 2) - Cathepsin L in Complex with (3S,14E)-19-Chloro-N-(1-Cyanocyclopropyl)- 5-Oxo-17-Oxa-4-Azatricyclo[16.2.2.06,11]Docosa-1(21),6,8,10,14, 18(22),19-Heptaene-3-Carboxamide
-
6f04 (Cl: 1) - N-Acetylglucosamine-2-Epimerase
-
6f05 (Cl: 9) - Arabidopsis Thaliana GSTF9, GSO3 Bound
-
6f06 (Cl: 4) - Cathepsin L in Complex with (3S,14E)-8-(Azetidin-3-Yl)-19-Chloro-N-(1- Cyanocyclopropyl)-5-Oxo-12,17-Dioxa-4-Azatricyclo[16.2.2.06, 11]Docosa-1(21),6,8,10,14,18(22),19-Heptaene-3-Carboxamide
Other atoms:
Zn (14);
-
6f0a (Cl: 2) - Crystal Structure of Human Indoleamine 2,3-Dioxygenase Bound to A Triazole Inhibitor and Alanine Molecule.
Other atoms:
Fe (2);
-
6f0i (Cl: 7) - Glic Mutant E26A
Other atoms:
Na (6);
-
6f0j (Cl: 7) - Glic Mutant E26A
Other atoms:
Na (6);
-
6f0m (Cl: 7) - Glic Mutant E35Q
Other atoms:
Na (6);
-
6f0n (Cl: 7) - Glic Mutant E82A
Other atoms:
Na (6);
-
6f0r (Cl: 4) - Glic Mutant E82Q
Other atoms:
Na (1);
-
6f0u (Cl: 7) - Glic Mutant E35A
Other atoms:
Na (6);
-
6f0v (Cl: 7) - Glic Mutant E82Q
Other atoms:
Na (6);
-
6f0z (Cl: 7) - Glic Mutant D88N
Other atoms:
Na (6);
-
6f10 (Cl: 7) - Glic Mutant D88N
Other atoms:
Na (6);
-
6f11 (Cl: 7) - Glic Mutant D86A
Other atoms:
Na (6);
-
6f12 (Cl: 7) - Glic Mutant E181A
Other atoms:
Na (6);
-
6f13 (Cl: 7) - Glic Mutant E75A
Other atoms:
Na (6);
-
6f15 (Cl: 7) - Glic Mutant H127Q
Other atoms:
Na (6);
-
6f16 (Cl: 7) - Glic Mutant H277Q
Other atoms:
Na (6);
-
6f1k (Cl: 1) - Structure of ARTD2/PARP2 Wgr Domain Bound to Double Strand Dna Without 5'Phosphate
-
6f1l (Cl: 1) - Lysozyme Crystallized in Presence of 100 Mm Sodium Phosphate at pH 4.5
Page generated: Fri May 13 21:47:50 2022
|
